We conducted a retrospective study by reviewing the medical records of 104 patients to assess the usefulness of the objective prognostic score (OPS) in an independent population of Korea. The median survival time (±standard error) of the high OPS group (≥3) was 9.0 ± 1.31 days and that of the low OPS group (<3) was 26.0 ± 3.3 days. The former was significantly shorter than the latter (P < .001). Only delirium (hazard ratio 1.751, P = .032) was related to shorter survival time independent of the OPS. This study demonstrates that the OPS is a valid and useful prognostic tool for predicting survival in terminally ill Korean patients with cancer, and that inclusion of delirium into the OPS may improve its prognostic value.
LoprinziCLJohnsonMESteerG. Doc, how much time do I have?J Clin Oncol. 2000;18(3):699–701.
2.
GlarePSinclairCDowningMStonePMaltoniMViganoA. Predicting survival in patients with advanced disease. Eur J Cancer. 2008;44(8):1146–1156.
3.
GrippSMoellerSBolkeE. Survival prediction in terminally ill cancer patients by clinical estimates, laboratory tests, and self-rated anxiety and depression. J Clin Oncol. 2007;25(22):3313–3320.
4.
MaltoniMCaraceniABrunelliC. Prognostic factors in advanced cancer patients: evidence based clinical recommendations—a study by the Steering Committee of the European Association for Palliative Care. J Clin Oncol. 2005;23(25):6240–6248.
5.
LauFCloutier-FisherDKuziemskyC. A systematic review of prognostic tools for estimating survival time in palliative care. J Palliat Care. 2007;23(2):93–112.
6.
PirovanoMMaltoniMNanniO. A new palliative prognostic score: a first step for the staging of terminally ill cancer patients. J Pain Symptom Manage. 1999;17(4):231–239.
7.
MaltoniMNanniOPirovanoM. Successful validation of the palliative prognostic score in terminally ill cancer patients. J Pain Symptom Manage. 1999;17(4):240–247.
8.
GlarePVirikK. Independent prospective validation of the PaP score in terminally ill patients referred to a hospital-based palliative medicine consultation service. J Pain Symptom Manage. 2001;22(5):891–898.
9.
GlarePAEychmuellerSMcMahonP. Diagnostic accuracy of the palliative prognostic score in hospitalized patients with advanced cancer. J Clin Oncol. 2004;22(23):4823–4828.
10.
MoritaTTsunodaJInoueS. The palliative prognostic index: a scoring system for survival prediction of terminally ill cancer patients. Support Care Cancer. 1999;7(3):128–133.
11.
LeeICKimCKSuhSY. Validation of scoring system for survival prediction in terminal cancer patinets in Korea. J Korean Acad Fam Med. 2007;28(9):682–689.
12.
SuhSYChoiYSShimJY. Construction of a new, objective prognostic score for terminally ill cancer patients: a multicenter study. Support Care Cancer. 2010;18(2):151–157.
13.
OkenMMCreechRHTormeyDC. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5(6):649–655.
14.
WachtelTAllen-MastersonSReubenDGoldbergRMorV. The end stage cancer patient: terminal common pathway. Hosp J. 1998;4(4):43–80.
15.
WalentaSMueller-KlieserWF. Lactate: mirror and motor of tumor malignancy. Semin Radiat Oncol. 2004;14(3):267–274.
16.
SuhSYAhnHY. Lactate dehydrogenase as a prognostic factor for survival time of terminally ill cancer patients: a preliminary study. Eur J Cancer. 2007;43(6):1051–1059.
17.
ChuangRBHuWYChiuTYChenCY. Prediction of survival in terminal cancer patients in Taiwan: constructing a prognostic scale. J Pain Symptom Manage. 2004;28(2):115–122.
18.
CaraceniANanniOMaltoniM. Impact of delirium on the short term prognosis of advanced cancer patients. Cancer. 2000;89(5):1145–1149.
19.
AltmanDGRoystonP. What do we mean by validating a prognostic model?Stat Med. 2000;19(4):453–473.
